JP2011102304A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011102304A5 JP2011102304A5 JP2010286329A JP2010286329A JP2011102304A5 JP 2011102304 A5 JP2011102304 A5 JP 2011102304A5 JP 2010286329 A JP2010286329 A JP 2010286329A JP 2010286329 A JP2010286329 A JP 2010286329A JP 2011102304 A5 JP2011102304 A5 JP 2011102304A5
- Authority
- JP
- Japan
- Prior art keywords
- unit dosage
- compound
- pathogenic cell
- host animal
- compound according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 CC[C@](CC1[C@](C)C1Cc(cc([C@](CC1)(C2N1CC=C[C@@]2(CC)[C@@]([C@@]1(*)O)O)C1(C)N1C)c1c1)c1OC)(CN(*)CCc1c(CC(OC)=O)[n]c2ccccc12)O Chemical compound CC[C@](CC1[C@](C)C1Cc(cc([C@](CC1)(C2N1CC=C[C@@]2(CC)[C@@]([C@@]1(*)O)O)C1(C)N1C)c1c1)c1OC)(CN(*)CCc1c(CC(OC)=O)[n]c2ccccc12)O 0.000 description 1
- CAAKXFHZUSSLMC-PTVYPEDCSA-N NCCCC(C(N[C@@H](CC(O)=O)C(N[C@@H](CC(O)=O)C(NC(CSSCCO)C(O)=O)=O)=O)=O)NC(C(CC(O)=O)NC(CC[C@@H](C(O)=O)NC(c(cc1)ccc1NCc(cn1)nc2c1N=C(N)NC2=O)=O)=O)=O Chemical compound NCCCC(C(N[C@@H](CC(O)=O)C(N[C@@H](CC(O)=O)C(NC(CSSCCO)C(O)=O)=O)=O)=O)NC(C(CC(O)=O)NC(CC[C@@H](C(O)=O)NC(c(cc1)ccc1NCc(cn1)nc2c1N=C(N)NC2=O)=O)=O)=O CAAKXFHZUSSLMC-PTVYPEDCSA-N 0.000 description 1
Claims (11)
- 下式の化合物、または、その薬理学的に受容可能な塩：
（式中、Ｄは、ビンクリスチン、ビンブラスチン、または、デアセチルビンブラスチンモノヒドラジドである。）
- Ｄは、デアセチルビンブラスチンモノヒドラジドであることを特徴とする、請求項１に記載の化合物。
- 下式の化合物、または、その薬理学的に受容可能な塩。
- 請求項１〜３のいずれか１項に記載の化合物と、一つ以上の、担体、希釈剤、または賦形剤、または、それらの組み合わせとを含む、製薬組成物。
- 請求項１〜３のいずれか１項に記載の化合物を含む単位投与剤であって、化合物は、宿主動物において病原性細胞集団によって引き起こされる病気の治療のために、治療学的に有効な量で存在することを特徴とする、単位投与剤。
- さらに、一つ以上の、担体、希釈剤、または賦形剤、または、それらの組み合わせを含む、請求項５に記載の単位投与剤。
- 病原性細胞集団がガンであることを特徴とする、請求項５または６に記載の単位投与剤。
- 宿主動物が人間であることを特徴とする、請求項５〜７のいずれか１項に記載の単位投与剤。
- 請求項１〜３のいずれか１項に記載の化合物、請求項４に記載の製薬組成物、または、請求項５〜８のいずれか１項に記載の単位投与剤の使用であって、宿主動物において病原性細胞集団を除去する薬を製造するための使用。
- 病原性細胞集団がガンであることを特徴とする、請求項９に記載の使用。
- 宿主動物が人間であることを特徴とする、請求項９または１０に記載の使用。
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US44284503P | 2003-01-27 | 2003-01-27 | |
| US60/442,845 | 2003-01-27 | ||
| US49211903P | 2003-08-01 | 2003-08-01 | |
| US60/492,119 | 2003-08-01 | ||
| US51618803P | 2003-10-31 | 2003-10-31 | |
| US60/516,188 | 2003-10-31 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2005518938A Division JP5576007B2 (ja) | 2003-01-27 | 2004-01-27 | ビタミン受容体結合性薬剤送達結合体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011102304A JP2011102304A (ja) | 2011-05-26 |
| JP2011102304A5 true JP2011102304A5 (ja) | 2011-09-15 |
| JP4815009B2 JP4815009B2 (ja) | 2011-11-16 |
Family
ID=32854293
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2005518938A Expired - Fee Related JP5576007B2 (ja) | 2003-01-27 | 2004-01-27 | ビタミン受容体結合性薬剤送達結合体 |
| JP2010286329A Expired - Fee Related JP4815009B2 (ja) | 2003-01-27 | 2010-12-22 | ビタミン受容体結合性薬剤送達結合体 |
| JP2011165553A Expired - Fee Related JP5721580B2 (ja) | 2003-01-27 | 2011-07-28 | ビタミン受容体結合性薬剤送達結合体 |
| JP2014246193A Withdrawn JP2015078215A (ja) | 2003-01-27 | 2014-12-04 | ビタミン受容体結合性薬剤送達結合体 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2005518938A Expired - Fee Related JP5576007B2 (ja) | 2003-01-27 | 2004-01-27 | ビタミン受容体結合性薬剤送達結合体 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011165553A Expired - Fee Related JP5721580B2 (ja) | 2003-01-27 | 2011-07-28 | ビタミン受容体結合性薬剤送達結合体 |
| JP2014246193A Withdrawn JP2015078215A (ja) | 2003-01-27 | 2014-12-04 | ビタミン受容体結合性薬剤送達結合体 |
Country Status (14)
| Country | Link |
|---|---|
| US (6) | US7601332B2 (ja) |
| EP (4) | EP2517729A3 (ja) |
| JP (4) | JP5576007B2 (ja) |
| AR (1) | AR042942A1 (ja) |
| AU (1) | AU2004210136C1 (ja) |
| CA (1) | CA2512867C (ja) |
| CY (1) | CY1113258T1 (ja) |
| DK (1) | DK1592457T3 (ja) |
| ES (1) | ES2395082T3 (ja) |
| IL (2) | IL169469A (ja) |
| NZ (1) | NZ541846A (ja) |
| PT (1) | PT1592457E (ja) |
| TW (3) | TWI367096B (ja) |
| WO (1) | WO2004069159A2 (ja) |
Families Citing this family (109)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7033594B2 (en) | 2000-03-31 | 2006-04-25 | Purdue Research Foundation | Method of treatment using ligand-immunogen conjugates |
| ATE427948T1 (de) * | 2001-04-24 | 2009-04-15 | Purdue Research Foundation | Folat-mimetika und deren folatrezeptorbindende konjugate |
| HUP0401127A3 (en) * | 2001-05-02 | 2006-03-28 | Purdue Research Foundation | Treatment and diagnosis of macrophage disease |
| WO2003028634A2 (en) * | 2001-09-28 | 2003-04-10 | Purdue Research Foundation | Method of treatment using ligand-immunogen conjugates |
| US8043603B2 (en) * | 2002-02-07 | 2011-10-25 | Endocyte, Inc. | Folate targeted enhanced tumor and folate receptor positive tissue optical imaging technology |
| US8043602B2 (en) | 2002-02-07 | 2011-10-25 | Endocyte, Inc. | Folate targeted enhanced tumor and folate receptor positive tissue optical imaging technology |
| EP1501551B1 (en) | 2002-05-06 | 2009-11-18 | Endocyte, Inc. | Folate-receptor targeted imaging agents |
| KR20040106547A (ko) * | 2002-05-15 | 2004-12-17 | 엔도사이트, 인코포레이티드 | 비타민-마이토마이신 공액체 |
| EP1534340B1 (en) | 2002-09-06 | 2011-11-16 | Cerulean Pharma Inc. | Cyclodextrin-based polymers for delivering the therapeutic agents covalently bound thereto |
| NZ541846A (en) * | 2003-01-27 | 2008-12-24 | Endocyte Inc | Vitamin receptor binding drug delivery conjugates |
| EP1629281B1 (en) | 2003-05-30 | 2008-10-29 | Purdue Research Foundation | Diagnostic method for atherosclerosis |
| FR2865736B1 (fr) * | 2004-02-02 | 2006-07-14 | Synt Em | Inhibiteurs de l'angiogenese, compositions les contenant et leur utilisation pour le traitement des maladies liees a une deregulation de l'angiogenese |
| EP1789391B1 (en) | 2004-07-23 | 2017-06-28 | Endocyte, Inc. | Bivalent linkers and conjugates thereof |
| TW200616604A (en) | 2004-08-26 | 2006-06-01 | Nicholas Piramal India Ltd | Nitric oxide releasing prodrugs containing bio-cleavable linker |
| AU2005281359A1 (en) | 2004-08-26 | 2006-03-16 | Apparao Satyam | Prodrugs and codrugs containing novel bio-cleavable disulfide linkers |
| JP2009221164A (ja) | 2008-03-17 | 2009-10-01 | Nitto Denko Corp | 肺線維症処置剤 |
| ES2443229T3 (es) | 2004-12-22 | 2014-02-18 | Nitto Denko Corporation | Portador de fármacos y kit portador de fármacos para la inhibición de la fibrosis |
| US20070276231A1 (en) * | 2004-12-23 | 2007-11-29 | Low Philip S | Positron Emission Tomography Imaging Method |
| WO2006101845A2 (en) * | 2005-03-16 | 2006-09-28 | Endocyte, Inc. | Synthesis and purification of pteroic acid and conjugates thereof |
| WO2006105141A1 (en) | 2005-03-30 | 2006-10-05 | Purdue Research Foundation | Method for cancer prognosis using cellular folate vitamin receptor quantification |
| EP1904183B1 (en) * | 2005-07-05 | 2014-10-15 | Purdue Research Foundation | Pharmaceutical composition for the treatment of osteoarthritis |
| WO2007022493A2 (en) * | 2005-08-19 | 2007-02-22 | Endocyte, Inc. | Ligand conjugates of vinca alkaloids, analogs, and derivatives |
| WO2007022494A2 (en) * | 2005-08-19 | 2007-02-22 | Endocyte, Inc. | Multi-drug ligand conjugates |
| EP1940473A2 (en) | 2005-09-23 | 2008-07-09 | Purdue Research Foundation | Multiphoton in vivo flow cytometry method and device |
| US9572886B2 (en) | 2005-12-22 | 2017-02-21 | Nitto Denko Corporation | Agent for treating myelofibrosis |
| WO2007089149A2 (en) * | 2006-02-02 | 2007-08-09 | Syntarga B.V. | Water-soluble cc-1065 analogs and their conjugates |
| US8168164B2 (en) * | 2006-02-03 | 2012-05-01 | Purdue Research Foundation | Targeted conjugates and radiation |
| CA2643826A1 (en) * | 2006-02-27 | 2008-06-12 | Paul A. Wender | Compositions and methods for transport of molecules with enhanced release properties across biological barriers |
| US20100226967A1 (en) * | 2006-05-23 | 2010-09-09 | Purdue Research Foundation | Imaging and therapeutic method using progenitor cells |
| AR061181A1 (es) * | 2006-05-25 | 2008-08-13 | Bristol Myers Squibb Co | Compuestos de aziridinil-epotilona |
| PE20080102A1 (es) * | 2006-05-25 | 2008-02-11 | Bristol Myers Squibb Co | Conjugados de analogos de aziridinil-epotilona y composiciones farmaceuticas que comprenden los mismos |
| US8685752B2 (en) | 2006-11-03 | 2014-04-01 | Purdue Research Foundation | Ex vivo flow cytometry method and device |
| TWI412367B (zh) * | 2006-12-28 | 2013-10-21 | Medarex Llc | 化學鏈接劑與可裂解基質以及其之綴合物 |
| JP2010516625A (ja) | 2007-01-24 | 2010-05-20 | インサート セラピューティクス， インコーポレイテッド | 制御された薬物送達のためのテザー基を有するポリマー−薬物コンジュゲート |
| CA2677792C (en) | 2007-02-07 | 2015-04-14 | Purdue Research Foundation | Positron emission tomography imaging method |
| US20100104626A1 (en) | 2007-02-16 | 2010-04-29 | Endocyte, Inc. | Methods and compositions for treating and diagnosing kidney disease |
| CL2008000510A1 (es) | 2007-02-21 | 2008-08-22 | Medarex Inc | Compuestos conjugados farmaco-ligandos, que se unen a citotoxinas potentes; composicion farmaceutica; y uso para retardar o detener el crecimiento de un tumor en un mamifero. |
| JP5829793B2 (ja) * | 2007-03-14 | 2015-12-09 | エンドサイト・インコーポレイテッドＥｎｄｏｃｙｔｅ， Ｉｎｃ． | 結合性リガンドが結合したツブリシンの薬剤送達結合体 |
| PT2150514T (pt) | 2007-04-11 | 2019-02-01 | Merck & Cie | Folatos etiquetados com 18f |
| EP2164525A2 (en) * | 2007-05-25 | 2010-03-24 | Purdue Research Foundation | Method of imaging localized infections |
| JP2010528115A (ja) * | 2007-05-25 | 2010-08-19 | ブリストル−マイヤーズ スクイブ カンパニー | エポチロン化合物およびアナログの製造方法 |
| US9877965B2 (en) | 2007-06-25 | 2018-01-30 | Endocyte, Inc. | Vitamin receptor drug delivery conjugates for treating inflammation |
| EP3569251A1 (en) * | 2007-06-25 | 2019-11-20 | Endocyte, Inc. | Conjugates containing hydrophilic spacer linkers |
| US9901567B2 (en) | 2007-08-01 | 2018-02-27 | Syntarga B.V. | Substituted CC-1065 analogs and their conjugates |
| EP3831380A3 (en) | 2007-08-17 | 2021-12-01 | Purdue Research Foundation | Psma binding ligand-linker conjugates and methods for using |
| EP2209374B1 (en) | 2007-10-25 | 2014-12-03 | Endocyte, Inc. | Tubulysins and processes for preparing |
| WO2009158633A1 (en) * | 2008-06-26 | 2009-12-30 | Curators Of The University Of Missouri On Behalf Of The University Of Missouri-Kansas City | Drug conjugates |
| CA2737496A1 (en) | 2008-09-17 | 2010-03-25 | Endocyte, Inc. | Folate receptor binding conjugates of antifolates |
| MX2011004625A (es) | 2008-11-03 | 2011-07-20 | Syntarga Bv | Analogos cc-1065 novedosos y sus conjugados. |
| CN104857534A (zh) * | 2009-07-31 | 2015-08-26 | 恩多塞特公司 | 叶酸盐靶向的诊断和治疗 |
| CN102612562A (zh) | 2009-08-27 | 2012-07-25 | 色奈普提科研究有限公司 | 一种新的用于生成诱导性多能干(iPS)细胞或组织特异性细胞的蛋白质递送系统 |
| WO2011027786A1 (ja) * | 2009-09-07 | 2011-03-10 | ニプロパッチ株式会社 | 経皮吸収型製剤 |
| WO2011069116A1 (en) * | 2009-12-04 | 2011-06-09 | Endocyte, Inc. | Binding ligand linked drug delivery conjugates of tubulysins |
| US9951324B2 (en) | 2010-02-25 | 2018-04-24 | Purdue Research Foundation | PSMA binding ligand-linker conjugates and methods for using |
| WO2011130716A2 (en) | 2010-04-16 | 2011-10-20 | Access Pharmaceuticals, Inc. | A nanostructures containing vitamin b12 for facilitated delivery of drugs across biological barriers |
| US9629924B2 (en) | 2010-04-21 | 2017-04-25 | Syntarga Bv | Conjugates of CC-1065 analogs and bifunctional linkers |
| JP5950428B2 (ja) | 2010-08-05 | 2016-07-13 | 日東電工株式会社 | 線維化組織から正常組織を再生するための組成物 |
| EP2600866A4 (en) | 2010-08-06 | 2013-12-11 | Endocyte Inc | PROCESS FOR THE PRODUCTION OF TUBULYSINES |
| AU2011325982C1 (en) * | 2010-11-12 | 2015-08-20 | Endocyte, Inc. | Methods of treating cancer |
| WO2012090104A1 (en) * | 2010-12-31 | 2012-07-05 | Kareus Therapeutics, Sa | Methods and compositions for designing novel conjugate therapeutics |
| KR20140026396A (ko) | 2011-03-08 | 2014-03-05 | 어섹스 팔마큐티칼스 인코포레이티드 | 생물학적 막을 가로질러 활성물질의 전달을 위한 표적화된 나노담체 시스템 |
| US20140030321A1 (en) * | 2011-04-12 | 2014-01-30 | Endocyte, Inc. | Solid pharmaceutical composition |
| WO2013126797A1 (en) | 2012-02-24 | 2013-08-29 | Purdue Research Foundation | Cholecystokinin b receptor targeting for imaging and therapy |
| WO2013130776A1 (en) | 2012-02-29 | 2013-09-06 | Purdue Research Foundation | Folate receptor alpha binding ligands |
| US20140080175A1 (en) | 2012-03-29 | 2014-03-20 | Endocyte, Inc. | Processes for preparing tubulysin derivatives and conjugates thereof |
| US9816066B2 (en) | 2012-04-24 | 2017-11-14 | The Regents Of The University Of California | Method for delivery of small molecules and proteins across the cell wall of algae using molecular transporters |
| KR102434075B1 (ko) | 2012-05-17 | 2022-08-19 | 익스텐드 바이오사이언시즈, 인크. | 개선된 약물 전달용 캐리어 |
| EP2708243A1 (en) | 2012-09-17 | 2014-03-19 | OntoChem GmbH | Receptor ligand linked cytotoxic molecules |
| US20140094432A1 (en) | 2012-10-02 | 2014-04-03 | Cerulean Pharma Inc. | Methods and systems for polymer precipitation and generation of particles |
| JP2015536323A (ja) | 2012-10-16 | 2015-12-21 | エンドサイト・インコーポレイテッドＥｎｄｏｃｙｔｅ， Ｉｎｃ． | 非天然アミノ酸を含む薬物送達結合体および使用方法 |
| CA3158675A1 (en) | 2012-11-15 | 2014-05-22 | Endocyte, Inc. | Drug delivery conjugates, and methods for treating diseases caused by psma expressing cells |
| JP6340162B2 (ja) | 2012-12-20 | 2018-06-06 | 日東電工株式会社 | アポトーシス誘導剤 |
| US20140249315A1 (en) | 2013-03-01 | 2014-09-04 | Endocyte, Inc. | Processes for preparing tubulysins |
| US9352049B2 (en) * | 2013-03-14 | 2016-05-31 | Albany Molecular Research, Inc. | Ligand-therapeutic agent conjugates, silicon-based linkers, and methods for making and using them |
| EP4095130B1 (en) | 2013-10-18 | 2024-01-31 | Novartis AG | Labeled inhibitors of prostate specific membrane antigen (psma), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer |
| CA2930581A1 (en) * | 2013-11-14 | 2015-05-21 | Endocyte, Inc. | Compounds for positron emission tomography |
| WO2015077303A1 (en) | 2013-11-19 | 2015-05-28 | Purdue Research Foundation | Patient selection method for inflammation |
| US20170168074A1 (en) | 2013-11-25 | 2017-06-15 | Ontochem Gmbh | Method for diagnosing G-protein coupled receptor-related diseases |
| ES2687225T3 (es) | 2014-01-10 | 2018-10-24 | Synthon Biopharmaceuticals B.V. | Método de purificación de conjugados anticuerpo-fármaco unidos a Cys |
| RU2769700C2 (ru) | 2014-01-10 | 2022-04-05 | Байондис Б.В. | Дуокармициновые adc, демонстрирующие улучшенную противоопухолевую активность in vivo |
| JP6224268B2 (ja) | 2014-01-10 | 2017-11-01 | シントン・バイオファーマシューティカルズ・ビー．ブイ．Ｓｙｎｔｈｏｎ Ｂｉｏｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｂ．Ｖ． | 子宮内膜癌の治療において使用するためのデュオカルマイシンａｄｃ |
| WO2015135659A1 (en) | 2014-03-14 | 2015-09-17 | Ontochem Gmbh | Receptor ligand linked cytotoxic molecules |
| CA2944417A1 (en) | 2014-04-02 | 2015-10-08 | Nitto Denko Corporation | A targeting molecule and a use thereof |
| KR102256453B1 (ko) | 2014-04-07 | 2021-05-25 | 닛토덴코 가부시키가이샤 | 소수성 약물 전달용 신규한 폴리머계 하이드로트로프 |
| US20170182117A1 (en) * | 2014-05-28 | 2017-06-29 | Stealth Biotherapeutics Corp | Therapeutic compositions including therapeutic small molecules and uses thereof |
| JP6298716B2 (ja) | 2014-05-30 | 2018-03-20 | 日立建機株式会社 | 作業機械 |
| CA2964463C (en) | 2014-10-22 | 2024-02-13 | Extend Biosciences, Inc. | Therapeutic vitamin d conjugates |
| WO2016065052A1 (en) | 2014-10-22 | 2016-04-28 | Extend Biosciences, Inc. | Insulin vitamin d conjugates |
| US9789197B2 (en) | 2014-10-22 | 2017-10-17 | Extend Biosciences, Inc. | RNAi vitamin D conjugates |
| US10188759B2 (en) | 2015-01-07 | 2019-01-29 | Endocyte, Inc. | Conjugates for imaging |
| EP3268046A4 (en) | 2015-03-13 | 2018-11-21 | Endocyte, Inc. | Conjugates for treating diseases |
| US10406238B2 (en) | 2015-05-11 | 2019-09-10 | Purdue Research Foundation | Ligand ionophore conjugates |
| US10420850B2 (en) | 2015-08-14 | 2019-09-24 | Endocyte, Inc. | Method of imaging with a chelating agent |
| WO2017147240A1 (en) | 2016-02-23 | 2017-08-31 | Tarveda Therapeutics, Inc. | Hsp90 targeted conjugates and particles and formulations thereof |
| WO2017161165A1 (en) | 2016-03-16 | 2017-09-21 | ChromaDex Inc. | B-vitamin and amino acid conjugates of nicotinoyl ribosides and reduced nicotinoyl ribosides, derivatives thereof, and methods of preparation thereof |
| WO2018182776A1 (en) * | 2016-03-29 | 2018-10-04 | Endocyte, Inc. | Folate conjugate for use in targeting tumor associated macrophages |
| CA3026651A1 (en) * | 2016-06-09 | 2017-12-14 | Blinkbio, Inc. | Silanol based therapeutic payloads |
| BR112019003811A2 (pt) | 2016-08-26 | 2019-05-21 | Exciva Ug (Haftungsbeschränkt) | composição farmacêutica, método para aumentar os níveis plasmáticos de antagonista do receptor de nmda em um sujeito que precisa do mesmo, método para tratar uma doença ou transtorno em um sujeito que precisa do mesmo e uso da composição |
| CA3045876A1 (en) | 2016-11-11 | 2018-05-17 | The Queen's University Of Belfast | Scalable syntheses of nicotinoyl ribosides and reduced nic otinoyl ribosides, modified derivatives thereof, phosphorylated analogs thereof, adenylyl dinucleotide conjugates thereof, and novel crystalline forms thereof |
| US11071747B2 (en) | 2016-11-29 | 2021-07-27 | University Of Iowa Research Foundation | Use of NAD precursors for breast enhancement |
| CA3044814A1 (en) | 2016-11-29 | 2018-06-07 | Charles M. Brenner | Use of nad precursors for improving maternal health and/or offspring health |
| US11197872B2 (en) | 2017-04-21 | 2021-12-14 | Lunella Biotech, Inc. | Vitamin C and doxycycline: a synthetic lethal combination therapy for eradicating cancer stem cells (CSCs) |
| CA3060509A1 (en) | 2017-04-21 | 2018-10-25 | Federica Sotgia | Targeting hypoxic cancer stem cells (cscs) with doxycycline: implications for improving anti-angiogenic therapy |
| CR20190524A (es) | 2017-05-19 | 2020-01-10 | Lunella Biotech Inc | Antimitoscinas: inhibidores específicos de la biogénesis mitocondrial para erradicar células madre cancerosas |
| EP3624897A4 (en) | 2017-05-19 | 2021-07-14 | Lunella Biotech, Inc. | COMPANION DIAGNOSIS FOR MITOCHONDRIAL INHIBITORS |
| JP7397672B2 (ja) | 2017-06-26 | 2023-12-13 | ルネラ・バイオテック・インコーポレーテッド | ミトケトシン：癌細胞におけるケトン代謝を標的とするミトコンドリアに基づく治療薬 |
| WO2019084323A1 (en) | 2017-10-25 | 2019-05-02 | Georgia State University Research Foundation, Inc. | CHEMICAL RELEASE SYSTEM DELIVERED BY ENRICHMENT |
| DK4103236T3 (en) | 2020-10-27 | 2023-11-13 | Elucida Oncology Inc | Folate receptor targeted nanoparticle drug conjugates and uses thereof |
| JP2024518097A (ja) * | 2021-05-14 | 2024-04-24 | パーデュー・リサーチ・ファウンデーション | 刷子縁膜酵素切断可能リンカーを持つ葉酸受容体標的コンジュゲート並びにガンのイメージング及び治療における使用方法 |
Family Cites Families (133)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2515483A (en) | 1946-08-10 | 1950-07-18 | Merck & Co Inc | Diacylated pteroic acid and process for preparing same |
| US2816110A (en) * | 1956-11-23 | 1957-12-10 | Merck & Co Inc | Methods for the production of substituted pteridines |
| US3392173A (en) | 1964-03-09 | 1968-07-09 | Lilly Co Eli | Novel acyl derivatives of desacetyl-vincaleukoblastine and processes for their preparation |
| US3387001A (en) | 1964-10-19 | 1968-06-04 | Lilly Co Eli | Novel aminoacyl esters of desacetyl vincaleukoblastine |
| US4203898A (en) | 1977-08-29 | 1980-05-20 | Eli Lilly And Company | Amide derivatives of VLB, leurosidine, leurocristine and related dimeric alkaloids |
| US4166810A (en) | 1978-04-20 | 1979-09-04 | Eli Lilly And Company | Derivatives of 4-desacetyl VLB C-3 carboxyhydrazide |
| US4337339A (en) | 1979-04-30 | 1982-06-29 | Baker Instruments Corp. | Process for preparation of folic acid derivatives |
| US4639456A (en) * | 1980-06-10 | 1987-01-27 | Omnichem S.A. | Vinblastin-23-oyl amino acid derivatives |
| US4316885A (en) * | 1980-08-25 | 1982-02-23 | Ayerst, Mckenna And Harrison, Inc. | Acyl derivatives of rapamycin |
| US4713249A (en) * | 1981-11-12 | 1987-12-15 | Schroeder Ulf | Crystallized carbohydrate matrix for biologically active substances, a process of preparing said matrix, and the use thereof |
| US5140104A (en) * | 1982-03-09 | 1992-08-18 | Cytogen Corporation | Amine derivatives of folic acid analogs |
| US4687808A (en) * | 1982-08-12 | 1987-08-18 | Biospecific Technologies, Inc. | Activation of biocompatible polymers with biologicals whose binding complements are pathological effectors |
| DE3376114D1 (en) | 1982-12-07 | 1988-05-05 | Kyowa Hakko Kogyo Kk | Mitomycin analogues |
| GR81790B (ja) * | 1983-04-29 | 1984-12-12 | Omnichem Sa | |
| US4866180A (en) | 1984-02-24 | 1989-09-12 | Bristol-Myers Company | Amino disulfide thiol exchange products |
| JPS60255789A (ja) * | 1984-06-01 | 1985-12-17 | Kyowa Hakko Kogyo Co Ltd | マイトマイシン誘導体，その製造法および抗腫瘍剤 |
| US5266333A (en) | 1985-03-06 | 1993-11-30 | American Cyanamid Company | Water dispersible and water soluble carbohydrate polymer compositions for parenteral administration of growth hormone |
| US4650803A (en) * | 1985-12-06 | 1987-03-17 | University Of Kansas | Prodrugs of rapamycin |
| US4801688A (en) | 1986-05-27 | 1989-01-31 | Eli Lilly And Company | Hydrazone immunoglobulin conjugates |
| IL82579A0 (en) | 1986-05-27 | 1987-11-30 | Lilly Co Eli | Immunoglobulin conjugates |
| WO1988001622A1 (en) | 1986-08-29 | 1988-03-10 | Kyowa Hakko Kogyo Kabusiki Kaisha | Mitomycin derivatives |
| US5120307A (en) * | 1988-06-21 | 1992-06-09 | Alcon Laboratories, Inc. | Method for injecting viscous fluid into the eye to life retinal membrane |
| US5094849A (en) | 1988-08-08 | 1992-03-10 | Eli Lilly And Company | Cytotoxic antibody conjugates of hydrazide derivatized vinca analogs via simple organic linkers |
| US5006652A (en) | 1988-08-08 | 1991-04-09 | Eli Lilly And Company | Intermediates for antibody-vinca drug conjugates |
| US5688488A (en) | 1989-04-03 | 1997-11-18 | Purdue Research Foundation | Composition and method for tumor imaging |
| US5108921A (en) | 1989-04-03 | 1992-04-28 | Purdue Research Foundation | Method for enhanced transmembrane transport of exogenous molecules |
| US5641487A (en) * | 1989-06-12 | 1997-06-24 | The Government Of The United States Of America As Represented By The Secretary Department Of Health And Human Services | Contraceptive vaccine based on alloimmunization with zona pellucida polypeptides |
| KR910009284A (ko) | 1989-11-13 | 1991-06-28 | 원본미기재 | 인체 종양 세포 항원에 특이적인 키메라형 생쥐-인체 a10 항체 |
| US5627165A (en) * | 1990-06-13 | 1997-05-06 | Drug Innovation & Design, Inc. | Phosphorous prodrugs and therapeutic delivery systems using same |
| US5998603A (en) * | 1994-09-29 | 1999-12-07 | Isis Pharmaceuticals, Inc. | 4'-desmethyl nucleoside analogs, and oligomers thereof |
| CA2090105A1 (en) | 1990-08-29 | 1992-03-01 | Jean-Paul Soulillou | Protein polyligands joined to a stable protein core |
| US5130307A (en) | 1990-09-28 | 1992-07-14 | American Home Products Corporation | Aminoesters of rapamycin |
| US5378696A (en) * | 1990-09-19 | 1995-01-03 | American Home Products Corporation | Rapamycin esters |
| US5221670A (en) * | 1990-09-19 | 1993-06-22 | American Home Products Corporation | Rapamycin esters |
| US5233036A (en) * | 1990-10-16 | 1993-08-03 | American Home Products Corporation | Rapamycin alkoxyesters |
| US5120842A (en) * | 1991-04-01 | 1992-06-09 | American Home Products Corporation | Silyl ethers of rapamycin |
| US5100883A (en) * | 1991-04-08 | 1992-03-31 | American Home Products Corporation | Fluorinated esters of rapamycin |
| US5194447A (en) * | 1992-02-18 | 1993-03-16 | American Home Products Corporation | Sulfonylcarbamates of rapamycin |
| US5118678A (en) * | 1991-04-17 | 1992-06-02 | American Home Products Corporation | Carbamates of rapamycin |
| US5138051A (en) * | 1991-08-07 | 1992-08-11 | American Home Products Corporation | Rapamycin analogs as immunosuppressants and antifungals |
| US5118677A (en) | 1991-05-20 | 1992-06-02 | American Home Products Corporation | Amide esters of rapamycin |
| US5169851A (en) * | 1991-08-07 | 1992-12-08 | American Home Products Corporation | Rapamycin analog as immunosuppressants and antifungals |
| US6335434B1 (en) * | 1998-06-16 | 2002-01-01 | Isis Pharmaceuticals, Inc., | Nucleosidic and non-nucleosidic folate conjugates |
| US5151413A (en) * | 1991-11-06 | 1992-09-29 | American Home Products Corporation | Rapamycin acetals as immunosuppressant and antifungal agents |
| US5159079A (en) * | 1991-12-20 | 1992-10-27 | Eli Lilly And Company | 2-piperidones as intermediates for 5-deaza-10-oxo- and 5-deaza-10-thio-5,6,7,8-tetrahydrofolic acids |
| US6004555A (en) | 1992-03-05 | 1999-12-21 | Board Of Regents, The University Of Texas System | Methods for the specific coagulation of vasculature |
| US5302584A (en) * | 1992-10-13 | 1994-04-12 | American Home Products Corporation | Carbamates of rapamycin |
| US5258389A (en) * | 1992-11-09 | 1993-11-02 | Merck & Co., Inc. | O-aryl, O-alkyl, O-alkenyl and O-alkynylrapamycin derivatives |
| US5260300A (en) * | 1992-11-19 | 1993-11-09 | American Home Products Corporation | Rapamycin carbonate esters as immuno-suppressant agents |
| ES2295093T3 (es) | 1993-04-23 | 2008-04-16 | Wyeth | Conjugados y anticuerpos de rapamicina. |
| US5391730A (en) * | 1993-10-08 | 1995-02-21 | American Home Products Corporation | Phosphorylcarbamates of rapamycin and oxime derivatives thereof |
| US5385910A (en) * | 1993-11-22 | 1995-01-31 | American Home Products Corporation | Gem-distributed esters of rapamycin |
| US5385909A (en) * | 1993-11-22 | 1995-01-31 | American Home Products Corporation | Heterocyclic esters of rapamycin |
| US5385908A (en) * | 1993-11-22 | 1995-01-31 | American Home Products Corporation | Hindered esters of rapamycin |
| US5389639A (en) * | 1993-12-29 | 1995-02-14 | American Home Products Company | Amino alkanoic esters of rapamycin |
| US5417982A (en) | 1994-02-17 | 1995-05-23 | Modi; Pankaj | Controlled release of drugs or hormones in biodegradable polymer microspheres |
| IL112873A (en) | 1994-03-08 | 2005-03-20 | Wyeth Corp | Rapamycin-fkbp12 binding proteins, their isolation and their use |
| US6171859B1 (en) | 1994-03-30 | 2001-01-09 | Mitokor | Method of targeting conjugate molecules to mitochondria |
| US5362718A (en) * | 1994-04-18 | 1994-11-08 | American Home Products Corporation | Rapamycin hydroxyesters |
| US5463048A (en) * | 1994-06-14 | 1995-10-31 | American Home Products Corporation | Rapamycin amidino carbamates |
| US5574018A (en) * | 1994-07-29 | 1996-11-12 | Amgen Inc. | Conjugates of vitamin B12 and proteins |
| US5491231A (en) * | 1994-11-28 | 1996-02-13 | American Home Products Corporation | Hindered N-oxide esters of rapamycin |
| US5547668A (en) | 1995-05-05 | 1996-08-20 | The Board Of Trustees Of The University Of Illinois | Conjugates of folate anti-effector cell antibodies |
| US6207157B1 (en) | 1996-04-23 | 2001-03-27 | The United States Of America As Represented By The Department Of Health And Human Services | Conjugate vaccine for nontypeable Haemophilus influenzae |
| US6030941A (en) * | 1996-05-01 | 2000-02-29 | Avi Biopharma, Inc. | Polymer composition for delivering substances in living organisms |
| WO1997041898A1 (en) * | 1996-05-03 | 1997-11-13 | Immunomedics, Inc. | Targeted combination immunotherapy of cancer |
| DE19621133A1 (de) | 1996-05-24 | 1997-11-27 | Boehringer Mannheim Gmbh | Bestimmungsverfahren mit oligomerisierten Rezeptoren |
| JP2001501601A (ja) | 1996-09-12 | 2001-02-06 | メルク エンド カンパニー インコーポレーテッド | 前立腺ガンの治療において有用な共役体 |
| US6056973A (en) * | 1996-10-11 | 2000-05-02 | Sequus Pharmaceuticals, Inc. | Therapeutic liposome composition and method of preparation |
| US6177404B1 (en) | 1996-10-15 | 2001-01-23 | Merck & Co., Inc. | Conjugates useful in the treatment of benign prostatic hyperplasia |
| US6071532A (en) | 1996-10-15 | 2000-06-06 | Emory University | Synthesis of glycophospholipid and peptide-phospholipid conjugates and uses thereof |
| US6291673B1 (en) | 1997-10-17 | 2001-09-18 | Purdue Research Foundation | Folic acid derivatives |
| GB9723669D0 (en) | 1997-11-07 | 1998-01-07 | Univ Aberdeen | Skin penetration enhancing components |
| US6380395B1 (en) | 1998-04-21 | 2002-04-30 | Bristol-Myers Squibb Company | 12, 13-cyclopropane epothilone derivatives |
| US6093382A (en) | 1998-05-16 | 2000-07-25 | Bracco Research Usa Inc. | Metal complexes derivatized with folate for use in diagnostic and therapeutic applications |
| CA2330611A1 (en) * | 1998-05-22 | 1999-12-02 | The Board Of Trustees Of The Leland Stanford Junior University | Bifunctional molecules and therapies based thereon |
| MXPA01006201A (es) | 1998-12-18 | 2003-06-06 | Hadasit Med Res Service | Metodo para administrar un compuesto a celulas resistentes a multiples medicamentos. |
| US6291684B1 (en) | 1999-03-29 | 2001-09-18 | Bristol-Myers Squibb Company | Process for the preparation of aziridinyl epothilones from oxiranyl epothilones |
| DE60030965T2 (de) | 1999-04-23 | 2007-05-24 | Alza Corp., Mountain View | Konjugate enthaltend eine spaltbare bindung zur anwendung in einem liposom |
| AUPQ014799A0 (en) * | 1999-05-04 | 1999-05-27 | Access Pharmaceuticals Australia Pty Limited | Amplification of folate-mediated targeting to tumor cells using polymers |
| AUPQ071299A0 (en) | 1999-06-02 | 1999-06-24 | Access Pharmaceuticals Australia Pty Limited | Vitamin directed dual targeting therapy |
| EP2269654A3 (en) * | 1999-08-24 | 2011-04-13 | Cellgate Inc. | Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties |
| MXPA02003771A (es) | 1999-10-15 | 2005-04-28 | Mayo Foundation | Conjugados de cobalamina, utiles como agentes para obtencion de imagen y como agentes anti-tumor. |
| US7067111B1 (en) * | 1999-10-25 | 2006-06-27 | Board Of Regents, University Of Texas System | Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging |
| US7033594B2 (en) | 2000-03-31 | 2006-04-25 | Purdue Research Foundation | Method of treatment using ligand-immunogen conjugates |
| US6670355B2 (en) | 2000-06-16 | 2003-12-30 | Wyeth | Method of treating cardiovascular disease |
| DE60106281T2 (de) | 2000-08-11 | 2005-02-24 | Wyeth | Verfahren zur Behandlung eines Östrogenrezeptor-positiven Karzinoms |
| CA2421485A1 (en) | 2000-09-19 | 2002-03-28 | Wyeth | Water soluble rapamycin esters |
| US6399625B1 (en) | 2000-09-27 | 2002-06-04 | Wyeth | 1-oxorapamycins |
| US6399626B1 (en) | 2000-10-02 | 2002-06-04 | Wyeth | Hydroxyesters of 7-desmethylrapamycin |
| US6440991B1 (en) | 2000-10-02 | 2002-08-27 | Wyeth | Ethers of 7-desmethlrapamycin |
| AU2002241524A1 (en) | 2000-11-28 | 2002-06-11 | Wyeth | Expression analysis of FKBP nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
| AR036993A1 (es) | 2001-04-02 | 2004-10-20 | Wyeth Corp | Uso de agentes que modulan la interaccion entre pd-1 y sus ligandos en la submodulacion de respuestas inmunologicas |
| PL367162A1 (en) | 2001-04-02 | 2005-02-21 | Wyeth | Pd-1, a receptor for b7-4, and uses therefor |
| ATE427948T1 (de) | 2001-04-24 | 2009-04-15 | Purdue Research Foundation | Folat-mimetika und deren folatrezeptorbindende konjugate |
| HUP0401127A3 (en) * | 2001-05-02 | 2006-03-28 | Purdue Research Foundation | Treatment and diagnosis of macrophage disease |
| US7109165B2 (en) | 2001-05-18 | 2006-09-19 | Sirna Therapeutics, Inc. | Conjugates and compositions for cellular delivery |
| JP2004532888A (ja) | 2001-06-01 | 2004-10-28 | ブリストル−マイヤーズ スクイブ カンパニー | エポチロン誘導体 |
| US20040018203A1 (en) | 2001-06-08 | 2004-01-29 | Ira Pastan | Pegylation of linkers improves antitumor activity and reduces toxicity of immunoconjugates |
| UA77200C2 (en) | 2001-08-07 | 2006-11-15 | Wyeth Corp | Antineoplastic combination of cci-779 and bkb-569 |
| ATE305932T1 (de) | 2001-08-22 | 2005-10-15 | Wyeth Corp | Rapanycin29-enole |
| JP2005503395A (ja) | 2001-08-22 | 2005-02-03 | ワイス | ラパマイシンジアルデヒド |
| WO2003028634A2 (en) | 2001-09-28 | 2003-04-10 | Purdue Research Foundation | Method of treatment using ligand-immunogen conjugates |
| GR1004163B (el) | 2001-11-01 | 2003-02-21 | Πολυκυκλικα παραγωγα τροποποιησης των οπτικων ιδιοτητων και των ιδιοτητων αντοχης στο πλασμα των πολυμερων λιθογραφιας | |
| US8043602B2 (en) | 2002-02-07 | 2011-10-25 | Endocyte, Inc. | Folate targeted enhanced tumor and folate receptor positive tissue optical imaging technology |
| US7000695B2 (en) | 2002-05-02 | 2006-02-21 | Halliburton Energy Services, Inc. | Expanding wellbore junction |
| EP1501551B1 (en) * | 2002-05-06 | 2009-11-18 | Endocyte, Inc. | Folate-receptor targeted imaging agents |
| US6596757B1 (en) * | 2002-05-14 | 2003-07-22 | Immunogen Inc. | Cytotoxic agents comprising polyethylene glycol-containing taxanes and their therapeutic use |
| KR20040106547A (ko) * | 2002-05-15 | 2004-12-17 | 엔도사이트, 인코포레이티드 | 비타민-마이토마이신 공액체 |
| EP1523493B1 (de) | 2002-07-09 | 2013-09-04 | Dömling, Alexander | Neue tubulysinanaloga |
| AU2003300027A1 (en) | 2002-10-10 | 2004-05-04 | Wyeth | Compositions, organisms and methodologies employing a novel human kinase |
| DE10254439A1 (de) | 2002-11-21 | 2004-06-03 | GESELLSCHAFT FüR BIOTECHNOLOGISCHE FORSCHUNG MBH (GBF) | Tubulysine, Herstellungsverfahren und Tubulysin-Mittel |
| JP2006516388A (ja) | 2002-11-21 | 2006-07-06 | ワイス | ループス腎炎の治療用組成物および方法 |
| NZ541846A (en) * | 2003-01-27 | 2008-12-24 | Endocyte Inc | Vitamin receptor binding drug delivery conjugates |
| AR042938A1 (es) | 2003-02-06 | 2005-07-06 | Wyeth Corp | Uso del cci-779 en el tratamiento de la fibrosis hepatica |
| EP1620544B1 (en) | 2003-04-17 | 2018-09-19 | Alnylam Pharmaceuticals Inc. | MODIFIED iRNA AGENTS |
| WO2004101803A2 (en) | 2003-05-12 | 2004-11-25 | Wyeth Holdings Corporation | Process for producing anticancer agent ll-d45042 |
| EP1646635A1 (en) | 2003-07-16 | 2006-04-19 | Wyeth | Cci-779 isomer c |
| WO2005016935A2 (en) | 2003-08-07 | 2005-02-24 | Wyeth | Regioselective synthesis of cci-779 |
| EP1789391B1 (en) | 2004-07-23 | 2017-06-28 | Endocyte, Inc. | Bivalent linkers and conjugates thereof |
| JP5192234B2 (ja) | 2004-08-10 | 2013-05-08 | アルナイラム ファーマシューティカルズ， インコーポレイテッド | 化学修飾オリゴヌクレオチド |
| WO2006101845A2 (en) | 2005-03-16 | 2006-09-28 | Endocyte, Inc. | Synthesis and purification of pteroic acid and conjugates thereof |
| WO2006105141A1 (en) | 2005-03-30 | 2006-10-05 | Purdue Research Foundation | Method for cancer prognosis using cellular folate vitamin receptor quantification |
| EP1904183B1 (en) | 2005-07-05 | 2014-10-15 | Purdue Research Foundation | Pharmaceutical composition for the treatment of osteoarthritis |
| WO2007022494A2 (en) | 2005-08-19 | 2007-02-22 | Endocyte, Inc. | Multi-drug ligand conjugates |
| WO2007022493A2 (en) | 2005-08-19 | 2007-02-22 | Endocyte, Inc. | Ligand conjugates of vinca alkaloids, analogs, and derivatives |
| PE20080102A1 (es) | 2006-05-25 | 2008-02-11 | Bristol Myers Squibb Co | Conjugados de analogos de aziridinil-epotilona y composiciones farmaceuticas que comprenden los mismos |
| US20100104626A1 (en) | 2007-02-16 | 2010-04-29 | Endocyte, Inc. | Methods and compositions for treating and diagnosing kidney disease |
| TW200841476A (en) | 2007-02-16 | 2008-10-16 | Mears Technologies Inc | Multiple-wavelength opto-electronic device including a superlattice and associated methods |
| JP5829793B2 (ja) | 2007-03-14 | 2015-12-09 | エンドサイト・インコーポレイテッドＥｎｄｏｃｙｔｅ， Ｉｎｃ． | 結合性リガンドが結合したツブリシンの薬剤送達結合体 |
| EP3569251A1 (en) | 2007-06-25 | 2019-11-20 | Endocyte, Inc. | Conjugates containing hydrophilic spacer linkers |
| US9877965B2 (en) * | 2007-06-25 | 2018-01-30 | Endocyte, Inc. | Vitamin receptor drug delivery conjugates for treating inflammation |
| CA2737496A1 (en) * | 2008-09-17 | 2010-03-25 | Endocyte, Inc. | Folate receptor binding conjugates of antifolates |
-
2004
- 2004-01-27 NZ NZ541846A patent/NZ541846A/en not_active IP Right Cessation
- 2004-01-27 AU AU2004210136A patent/AU2004210136C1/en not_active Ceased
- 2004-01-27 EP EP12004279A patent/EP2517729A3/en not_active Withdrawn
- 2004-01-27 TW TW093101735A patent/TWI367096B/zh not_active IP Right Cessation
- 2004-01-27 EP EP04705573A patent/EP1592457B1/en not_active Expired - Lifetime
- 2004-01-27 CA CA2512867A patent/CA2512867C/en not_active Expired - Fee Related
- 2004-01-27 DK DK04705573.6T patent/DK1592457T3/da active
- 2004-01-27 EP EP12004281A patent/EP2517730A3/en not_active Withdrawn
- 2004-01-27 PT PT04705573T patent/PT1592457E/pt unknown
- 2004-01-27 TW TW102113366A patent/TWI492750B/zh not_active IP Right Cessation
- 2004-01-27 JP JP2005518938A patent/JP5576007B2/ja not_active Expired - Fee Related
- 2004-01-27 EP EP12004280A patent/EP2529758A3/en not_active Withdrawn
- 2004-01-27 US US10/765,336 patent/US7601332B2/en not_active Expired - Fee Related
- 2004-01-27 AR ARP040100241A patent/AR042942A1/es not_active Application Discontinuation
- 2004-01-27 ES ES04705573T patent/ES2395082T3/es not_active Expired - Lifetime
- 2004-01-27 TW TW101108172A patent/TWI405573B/zh not_active IP Right Cessation
- 2004-01-27 WO PCT/US2004/002070 patent/WO2004069159A2/en active Application Filing
-
2005
- 2005-06-30 IL IL169469A patent/IL169469A/en not_active IP Right Cessation
-
2009
- 2009-07-10 US US12/501,283 patent/US8105568B2/en not_active Expired - Fee Related
-
2010
- 2010-12-22 JP JP2010286329A patent/JP4815009B2/ja not_active Expired - Fee Related
-
2011
- 2011-07-28 JP JP2011165553A patent/JP5721580B2/ja not_active Expired - Fee Related
- 2011-09-07 US US13/199,654 patent/US20120065149A1/en not_active Abandoned
-
2012
- 2012-10-25 CY CY20121101011T patent/CY1113258T1/el unknown
-
2013
- 2013-03-05 US US13/785,523 patent/US20140058063A1/en not_active Abandoned
-
2014
- 2014-12-04 JP JP2014246193A patent/JP2015078215A/ja not_active Withdrawn
-
2015
- 2015-05-21 IL IL238935A patent/IL238935A0/en unknown
- 2015-08-26 US US14/836,255 patent/US20160220694A1/en not_active Abandoned
-
2018
- 2018-03-26 US US15/936,393 patent/US20190216934A9/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011102304A5 (ja) | ||
| JP2012255026A5 (ja) | ||
| JP2013509429A5 (ja) | ||
| CY1119490T1 (el) | Παραγωγα πυραζολοπυρρολιδινης και η χρηση τους στην θεραπεια νοσηματων | |
| CY1121781T1 (el) | Φαρμακοτεχνικες μορφες παρατεταμενης απελευθερωσης της ρασαγιλινης και χρησεις αυτων | |
| JP2017524735A5 (ja) | ||
| JP2015078230A5 (ja) | ||
| JP2016501221A5 (ja) | ||
| JP2012532874A5 (ja) | ||
| JP2014521735A5 (ja) | ||
| JP2014221779A5 (ja) | ||
| JP2015536964A5 (ja) | ||
| JP2012525393A5 (ja) | ||
| JP2008535785A5 (ja) | ||
| JP2015501783A5 (ja) | ||
| JP2015516419A5 (ja) | ||
| JP2013522326A5 (ja) | ||
| JP2013014622A5 (ja) | ||
| JP2014526503A5 (ja) | ||
| JP2020097577A5 (ja) | ||
| JP2015532296A5 (ja) | ||
| JP2015511609A5 (ja) | ||
| AR083528A1 (es) | Analogos de peptido insulinotropico dependiente de glucosa | |
| JP2011046708A5 (ja) | ||
| RU2017141536A (ru) | Замещенные производные индол-5-ола и их терапевтические применения |